PBMs contact Congress over proposed USPS five-day delivery schedule
FDA puts a spotlight on cargo theft of life sciences products
FDA-run website will provide a single point of reference
Study finds 30% of patients interested in new technologies and devices that remind them to take prescription medicine
New study sets benchmark for post-marketing surveillance process
Gaps found in gray areas like adverse events reported on blogs and interactive web events
Comparative effectiveness research gets boost with healthcare overhaul law
PPACA provides $3 billion in funding and creates new Patient-Centered Outcomes Research Institute
Global pharma growth will be 5-8% annually through 2014, predicts IMS Health
‘Pharmerging’ markets will provide half the boost to 2014’s $1.1-trillion market
ValueCentric offers a New Product Launch service leveraging CVS Caremark trade data
Service builds on ValueCentrics’ ValueTrak channel-data tracking capability
New United BioSource partnership steps up expertise across Asia-Pacific markets
Singapore-based Clearstate will help UBC clients navigate complex reimbursements policies
NanoGuardian one step closer to delivering early-warning anti-counterfeiting system
Altegrity Risk International named security partner in Closed-Loop Protection Program
Diplomat Specialty Pharmacy poised for growth in Michigan
Specialty pharmacy wins $61.5M in tax credits and $14M in grants for 1,000-plus jobs
Cancer drug Avastin tops forecast for 2014's top-selling drugs worldwide
Blockbusters Lipitor and Plavix disappear from list due to patent expirations
Prime Therapeutics identifies factors influencing drug adherence
90-day supplies and lower out-of-pocket expenses positively impact compliance
FDA Approves Harder-to-Abuse OxyContin Formulation
Reformulated drug is a ‘step in the right direction,’ says FDA director
Time Is Running Out on Unused Stocks of H1N1 Vaccine
CDC to release action plan for dealing with unused or expired swine flu vaccine
Follow the Money... Where Healthcare Policy is Headed
CMS will be changing reimbursement practices regardless of how healthcare reform plays out
AstraZeneca's Principles for Product-Related Online Communications
Industry anticipates meaningful guidance from FDA on use of social media
How Well Can Biopharma Protect Itself Against Theft?
Monetizing Intellectual Property: Royalties, Revenues and Alternative Sources of Capital
Investment funds have developed an interest in trading capital for royalties on drug commercializations
Look for Flexibility In Your CRM or SFA System
Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?
True Software-as-a-Service (SaaS) Transforms Sales Automation Systems to Make Upgrades Painless
Multi-tenant sales-force automation (SFA) systems are coping with an increasingly complex regulatory environment
Optimization of 2-8 Degrees Celsius Controlled-Temperature Small Parcels
Leveraging the EHR to Advance Clinical Research
Converging the processes and data from EHRs and from the electronic data-capture (EDC) of the clinical research environment could change the paradigm of drug development and safety
Injectable-Drug Market Continues Moving Toward Plastics and Prefilled Syringes
Parenteral (injectable) drugs gain user acceptance even as biotech brings more of them onto the market
Get Ready for Pharma 3.0, Says Ernst & Young in Its Annual Progressions Report
The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients
Industry Sets Its Social-Media Regulatory Position With DDMAC
PhRMA pushes for an FDA ‘universal symbol’ of approved content, and seeks latitude in communications in online forums
Global Growth Will Accelerate in 'Pharmerging' Countries, Says IMS Health
Big Pharma is not yet deeply enough invested in faster-growing markets outside the developed economies
SupplyScape, reborn as TraceLink, is back with the
Pedigree-pioneering team resurfaces with cloud-based collaborative platform
Today's global biopharma cold-chain market is $5.1 billion, growing to $6.6 billion by 2011
FDA's DDMAC Takes Another Stab at Enforcing Fair Balance in Drug Advertising
Agency strives to balance risks and benefits in how drugs are presented in direct-to-consumer (DTC) campaigns
